Cyteir Therapeutics, Inc.

Cyteir is revolutionizing the concept of DNA damage and repair. Conventional therapies focus on reversal of cancer cell properties and DNA damage to restore the normal state. Cyteir takes a contrarian approach by enhancing – not reducing – DNA damage to achieve rapid and selective elimination of only the diseased cells. On this basis Cyteir has developed and is now leveraging an integrated drug development platform to deliver a pipeline of small molecule therapeutics with a broad range of potential disease state applications.

Focus area
Commencement date